- $64.53m
- $64.66m
- CNY1.85bn
Annual income statement for Youlife, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | 20-F |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 724 | 1,366 | 1,586 | 1,854 |
| Cost of Revenue | ||||
| Gross Profit | 127 | 200 | 229 | 192 |
| Selling / General / Administrative Expenses | ||||
| Research And Development | ||||
| Unusual Expense / Income | ||||
| Total Operating Expenses | 878 | 1,355 | 1,554 | 1,843 |
| Operating Profit | -153 | 10.4 | 31.7 | 11.6 |
| Total Net Non Operating Interest Income / Expense | ||||
| Other Net Non Operating Costs | ||||
| Net Income Before Taxes | -72.5 | 49 | -41.3 | 50.5 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -91.1 | 79.3 | -52.4 | 42.7 |
| Minority Interest | ||||
| Net Income Before Extraordinary Items | ||||
| Extraordinary Items | ||||
| Net Income | -93.5 | 99.3 | -52.4 | 43.1 |
| Adjustments to Net Income | ||||
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -224 | 99.3 | -52.4 | 43.1 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -2.99 | 0.821 | -0.613 | 0.513 |